CREDIT AGREEMENT dated as of March 19, 2015 among REGENERON PHARMACEUTICALS, INC. REGENERON HEALTHCARE SOLUTIONS, INC. REGENERON GENETICS CENTER LLC REGENERON INTERNATIONAL REGENERON IRELAND HOLDINGS REGENERON IRELAND REGENERON CAPITAL INTERNATIONAL...Credit Agreement • March 23rd, 2015 • Regeneron Pharmaceuticals Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT (this “Agreement”) dated as of March 19, 2015 among REGENERON PHARMACEUTICALS, INC., a New York corporation, REGENERON HEALTHCARE SOLUTIONS, INC., a New York corporation, REGENERON GENETICS CENTER LLC, a Delaware limited liability company, REGENERON INTERNATIONAL, an unlimited company incorporated in Ireland, REGENERON IRELAND HOLDINGS, an unlimited company incorporated in Ireland, REGENERON IRELAND, an unlimited company incorporated in Ireland, REGENERON CAPITAL INTERNATIONAL B.V., a besloten vennootschap met beperkte aansprakelijkheid organized under the laws of the Netherlands, the other SUBSIDIARY BORROWERS from time to time party hereto, the LENDERS from time to time party hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent, BANK OF AMERICA, N.A. and U.S. BANK NATIONAL ASSOCIATION, as Co-Syndication Agents, and BARCLAYS BANK PLC, CITIBANK, N.A., CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, FIFTH THIRD BANK and MORGAN STANLEY MUFG LOAN PARTNERS, LLC, as Co-Docum
